test

Flynn Management LLC, its general partner

@Deerfield Management Company, L.p. (series C)

Latest period2024 - Q3ReportedManaged Assets$6.693BTotal holdings443
Assets growth rate11.36%Assets growth rate (2-Q avg)7.96%Continuous growth in asset value4 quarters

Portfolio positions

This chart displays the top 10 holdings in Deerfield Management Company, L.p. (series C)'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 443 positions.

Assets under management

The assets under management (AUM) of Deerfield Management Company, L.p. (series C) over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.693B in assets, with a quarterly growth rate of 11.36% and a 2-quarter average growth rate of 7.96%. The portfolio is managed by Flynn Management LLC, its general partner, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CNMDConmed Corp
Recent Activity
Decreased -2.59%
0.67%
$44.223M
614,890 shares@ $71.93 avg price
DAWNDay One Biopharmaceuticals I
Recent Activity
Decreased -10.44%
0.55%
$36.465M
2.618M shares@ $13.93 avg price
PODDInsulet Corp
Recent Activity
Decreased -2.51%
0.39%
$25.509M
109,600 shares@ $232.75 avg price
BNTXBiontech Se
Recent Activity
Decreased -70.62%
0.31%
$20.725M
174,500 shares@ $118.77 avg price
NKTXNkarta Inc
Recent Activity
Decreased -43.27%
0.15%
$9.741M
2.155M shares@ $4.52 avg price
PRLDPrelude Therapeutics Inc
Recent Activity
Decreased -8.87%
0.12%
$7.796M
3.766M shares@ $2.07 avg price
ALECAlector Inc
Recent Activity
Decreased -8.11%
0.08%
$4.917M
1.055M shares@ $4.67 avg price
KYTXKyverna Therapeutics Inc
Recent Activity
Decreased -53.66%
0.07%
$4.493M
918,892 shares@ $4.9 avg price
HLVXHillevax Inc
Recent Activity
Decreased -52.98%
0.05%
$3.313M
1.883M shares@ $1.76 avg price
LOWLowes Cos Inc
Recent Activity
Decreased -27.11%
0.03%
$1.602M
5,913 shares@ $270.85 avg price